#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Multiple system atrophy Pseudoxanthoma elasticum Follicle centre lymphoma follicular grade I II – III refractory Alagille syndrome Acquired ATTR amyloidosis Usher's syndrome Malignant melanoma Transferrin decreased Vulval cancer recurrent Neuroendocrine cell hyperplasia of infancy B-cell small lymphocytic lymphoma recurrent Cognitive disorder Tuberous sclerosis complex Amyotrophic lateral sclerosis Ocular myasthenia More trials…

    Learn about Rare Diseases

    Pemphigoid – Diagnostics Cystic fibrosis lung Rosai-Dorfman syndrome – Treatment Richter’s syndrome – Life with Disease Myelodysplastic syndrome with excess blasts – Life with Disease Hereditary ataxia – Basic Information Marginal zone lymphoma refractory – Diagnostics Chordoma – Diagnostics Congenital generalised lipodystrophy – Treatment Chondrosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Haloperidol Decanoate Argon Mps-103 Adalimumab Cefotaxime Lna043 Tamsulosin Hydrochloride Remibrutinib Propofol Omp65 Setrusumab Octreotide Hydrochloride Mk-0482 Tamibarotene Etidronate Disodium Tozinameran Minoxidil Mosliciguat Sodium Laurilsulfate Ceritinib More therapies…

    Learn about Your Condition

    Multifocal motor neuropathy Gingival bleeding Pulmonary sarcoidosis Seasonal allergy Myxofibrosarcoma Haemodynamic instability Myocarditis post infection Prostate cancer Herpes virus infection Hydrocele Vulval cancer recurrent Vulvovaginal candidiasis Actinic cheilitis H1N1 influenza Toxic nodular goitre More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU Croix Rousse-Lyon

CHU Croix Rousse-Lyon

103 Grande Rue De La Croix Rousse, Lyon, 69317, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Chemotherapy with Cisplatin, Fluorouracil, and Docetaxel for Patients with Locally Advanced Squamous Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic squamous cell carcinoma
    Investigated Drugs:
    • Cisplatin
    • Docetaxel
    • Fluorouracil
    France

  • Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

    Not recruiting

    3 1
    Investigated Drugs:
    • Resmetirom
    Austria Belgium France Germany Hungary Italy +2

  • Study on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis

    Not recruiting

    4 1
    Investigated Diseases:
    • Hepatic cirrhosis
    • Varices oesophageal
    Investigated Drugs:
    • Galactoarabino-Rhamnogalacturonate
    Belgium France Germany Poland Spain

  • Study on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Baricitinib
    • Fluorescein Sodium
    • Prednisone
    France

  • Study on the Effects of VS-01 for Adults with Acute-on-Chronic Liver Failure and Ascites

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute on chronic liver failure
    Investigated Drugs:
    • Citric Acid, Anhydrous Ph. Eur.
    Belgium France Germany Hungary Italy Spain

  • Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Glucose
    • Durvalumab
    • Infliximab
    Belgium France Germany Greece Italy The Netherlands +2

  • Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ab-729
    • Durvalumab
    France Poland Romania Spain

  • Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Benralizumab
    • Depemokimab
    • Mepolizumab
    Austria Finland France Germany Ireland Italy +6

  • Study on the Effectiveness of Pembrolizumab and Lenvatinib for Patients with Resectable Mucosal Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    France

  • Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Goserelin
    • Letrozole
    Austria Belgium France Germany Hungary Ireland +4
Previous Page
1 … 8 9 10 11 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!